Effectiveness Evaluation of a Mobile Application for Rheumatoid Arthritis

NCT06873607 | Completed

• 1 other identifier: RA mobile app
• Study Type: interventional
• Target: 90
• Locations: 1 country
• Sites: 2

Brief Summary

The aim of this experimental study is to develop a mobile application for patients with rheumatoid arthritis based on evidence-based recommendations and to evaluate the effectiveness of the developed application. Research Questions

1. 1.Is the mobile application developed for patients with rheumatoid arthritis effective in improving their quality of life?
2. 2.Is the mobile application developed for patients with rheumatoid arthritis effective in reducing their disease activity? The researchers will enable the intervention group to use the mobile application in order to assess its effectiveness, while the control group will receive routine care throughout the study period.

Conditions

Rheumatoid Arthritis; Mobile Application

Keywords

rheumatoid arthritis; mobile application; nursing; quality of life; disease activity

Outcome Measures

Primary Outcomes (2)

• Disease Activity Score 28

  It is a scoring system used to determine the disease activity of rheumatoid arthritis. Calculation is made by evaluating the number of tender and swollen joints, erythrocyte sedimentation rate, global assessment of the patient, and VAS measurements using a special type of calculator. Based on the obtained DAS score, DAS 28 ≤ 2.4 is considered remission, 2.4-3.6 indicates low disease activity, 3.6-5.5 indicates moderate disease activity, and ≥ 5.5 is classified as high disease activity.

  Baseline and 12 weeks after intervention

• The Rheumatoid Arthritis Quality of Life Questionnaire-RAQoL

  It will evaluate the quality of life of individuals with rheumatoid arthritis.The obtained result ranges from 0 to 30, with higher scores indicating poorer quality of life.

  Baseline and 12 weeks after intervention.

Secondary Outcomes (7)

• Mediterranean Diet Adherence Screener-MEDAS

  Baseline and 12 weeks after intervention

• International Physical Activity Questionnaire Short Form-IPAQ-SF

  Baseline and 12 weeks after intervention

• The Stanford Health Assessment Questionnaire-HAQ

  Baseline and 12 weeks after intervention

• Bristol Rheumatoid Arthritis Fatigue Multi-Dimensional Questionnaire-BRAF-MDQ-T

  Baseline and 12 weeks after intervention

• Perceived Stressed Scale-PSS-14

  Baseline and 12 weeks after intervention

Study Arms (2)

Mobile app care

EXPERIMENTAL

Participants in this group will receive mobile application-supported care for 12 weeks, along with the recommended treatment. The content of the mobile application will include information about the disease, recommended lifestyle changes, as well as exercise and nutrition suggestions.

Device: mobile app

Control

OTHER

These patients will not use the mobile application and will continue to receive standard treatment and care.

Other: Control (Standard treatment)

Interventions

mobile app DEVICE

Mobile application content: general information about rheumatoid arthritis (causes, symptoms, treatment), lifestyle changes, coping strategies for symptoms, nutrition and exercise recommendations, and daily life considerations.

Also known as: standard treatment and care

Mobile app care

Control (Standard treatment) OTHER

Routine medical check-ups and the information provided during these visits

Control

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Be 18 years of age or older
• Diagnosis of Rheumatoid Arthritis according to the American College of Rheumatology (ACR) 1987 criteria
• Receiving stable treatment for the last 3 months with no new treatments added at the last check-up
• Ability to read and write in Turkish
• Ownership of a personal smartphone with internet connectivity and the ability to use an application
• Willingness to participate in the study

You may not qualify if:

• Pregnancy or breastfeeding
• Having a diagnosis of inflammatory diseases or a disease that may significantly affect the functional status (such as Multiple Sclerosis, stroke, Systemic Lupus Erythematosus, Ankylosing Spondylitis, Psoriatic Arthritis)
• Not having any neurological or psychiatric disease/problem diagnosed by a physician
• Wanting to withdraw from the study
• Exiting during the study process
• Not logging in to the mobile application once a week during the study implementation period (twelve weeks) for the intervention group

Sponsors & Collaborators

• Kırıkkale University: lead

Study Sites (2)

University of Health Science Gulhane Training and Research Hospital

Ankara, Yahşihan, Turkey (Türkiye)

Location

University of Health Science Gulhane Training and Research Hospital

Ankara, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Arthritis, Rheumatoid

Condition Hierarchy (Ancestors)

Arthritis; Joint Diseases; Musculoskeletal Diseases; Rheumatic Diseases; Connective Tissue Diseases; Skin and Connective Tissue Diseases; Autoimmune Diseases; Immune System Diseases

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: SUPPORTIVE CARE
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Msc

Study Record Dates

• First Submitted: March 7, 2025
• First Posted: March 12, 2025
• Study Start: July 1, 2025
• Primary Completion: January 31, 2026
• Study Completion: January 31, 2026
• Last Updated: April 13, 2026

Record last verified: 2025-07

Data Sharing

• IPD Sharing: Will not share

Locations

TU (2)